|
|
|
|
|
|
|
|
|
|
||
|
|
Safeguard Biosystems is commercializing rapid, cost-effective, molecular diagnostic technologies and tests with exceptional performance. These can be effectively used for mass surveillance and selective screening for pathogens and other agents for agriculture, food safety, genetic screening and human health applications. |
|
||
|
|
Tests being developed are based on two complementary platforms: |
|
||
|
|
|
|
||
|
|
The LFD allows users to undertake initial test screening directly on site, giving results in minutes. LFDs can be used for a wide range of single pathogens in a sample. The process is simple, reliable and affordable. |
|
||
|
|
The 3D SensorArray™ used with a BioSCAN™unit is an advanced system that offers quantitative detection of many different pathogens in a single test. The BioSCAN™ is a sophisticated imaging and analysis unit with integrated test workflow and robotic fluidic system. |
|
||
|
|
Patented technologies enable the LFD to act as a sample retention device that can be used as a source of material for subsequent in-depth 3D SensorArray™ tests. The integratation of these platforms is unique to Safeguard Biosystems. |
|
||
|
|
Diagnostic tests currently being launched or in development include tests for detecting Influenza A, multiple pathogens in milk, viruses in cattle and toxins such as botulism in food; the authentication of food at a genetic level and screening for the Human Papilloma Virus (HPV). |
|
||
|
|
In the development of our technologies and tests we have worked with leading scientific institutions such as Argonne National Laboratory (US Government), the US Department of Agriculture, the Veterinary and Central Science Laboratory Agencies (UK Government), IMTEK (Germany), Vaccine and Infectious Disease Organization (Canada) and the Canadian Centre for DNA Barcoding. |
|
||
|
|
Safeguard Biosystems operates in North America, the United Kingdom and Germany. |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
||||
